Logo image of BZUN

BAOZUN INC-SPN ADR (BZUN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BZUN - US06684L1035 - ADR

2.86 USD
+0.09 (+3.25%)
Last: 11/28/2025, 1:30:02 PM
Fundamental Rating

3

BZUN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 30 industry peers in the Broadline Retail industry. BZUN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BZUN is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year BZUN has reported negative net income.
BZUN had negative earnings in 4 of the past 5 years.
Of the past 5 years BZUN 4 years had a positive operating cash flow.
BZUN Yearly Net Income VS EBIT VS OCF VS FCFBZUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M -600M

1.2 Ratios

BZUN has a worse Return On Assets (-1.92%) than 63.33% of its industry peers.
The Return On Equity of BZUN (-4.88%) is worse than 60.00% of its industry peers.
Industry RankSector Rank
ROA -1.92%
ROE -4.88%
ROIC N/A
ROA(3y)-3.64%
ROA(5y)-1.73%
ROE(3y)-9.17%
ROE(5y)-5.01%
ROIC(3y)N/A
ROIC(5y)N/A
BZUN Yearly ROA, ROE, ROICBZUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 -15

1.3 Margins

The Gross Margin of BZUN (73.15%) is better than 96.67% of its industry peers.
In the last couple of years the Gross Margin of BZUN has grown nicely.
The Profit Margin and Operating Margin are not available for BZUN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.23%
GM growth 5Y3.57%
BZUN Yearly Profit, Operating, Gross MarginsBZUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

BZUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BZUN has less shares outstanding
BZUN has less shares outstanding than it did 5 years ago.
BZUN has a worse debt/assets ratio than last year.
BZUN Yearly Shares OutstandingBZUN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
BZUN Yearly Total Debt VS Total AssetsBZUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.37, we must say that BZUN is in the distress zone and has some risk of bankruptcy.
BZUN's Altman-Z score of 1.37 is in line compared to the rest of the industry. BZUN outperforms 53.33% of its industry peers.
BZUN has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.42, BZUN perfoms like the industry average, outperforming 46.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Altman-Z 1.37
ROIC/WACCN/A
WACC2.49%
BZUN Yearly LT Debt VS Equity VS FCFBZUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

BZUN has a Current Ratio of 1.97. This is a normal value and indicates that BZUN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BZUN (1.97) is better than 63.33% of its industry peers.
BZUN has a Quick Ratio of 1.69. This is a normal value and indicates that BZUN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BZUN (1.69) is better than 76.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.69
BZUN Yearly Current Assets VS Current LiabilitesBZUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

3

3. Growth

3.1 Past

The earnings per share for BZUN have decreased strongly by -22.88% in the last year.
The Revenue has been growing slightly by 6.92% in the past year.
Measured over the past years, BZUN shows a small growth in Revenue. The Revenue has been growing by 5.30% on average per year.
EPS 1Y (TTM)-22.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.85%
Revenue 1Y (TTM)6.92%
Revenue growth 3Y0.09%
Revenue growth 5Y5.3%
Sales Q2Q%1.11%

3.2 Future

BZUN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 84.98% yearly.
BZUN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.95% yearly.
EPS Next Y276.97%
EPS Next 2Y134.34%
EPS Next 3Y99.3%
EPS Next 5Y84.98%
Revenue Next Year5.49%
Revenue Next 2Y4.54%
Revenue Next 3Y4.34%
Revenue Next 5Y4.95%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BZUN Yearly Revenue VS EstimatesBZUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
BZUN Yearly EPS VS EstimatesBZUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4 6 8

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BZUN. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 8.12, which indicates a very decent valuation of BZUN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BZUN indicates a rather cheap valuation: BZUN is cheaper than 90.00% of the companies listed in the same industry.
BZUN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.59.
Industry RankSector Rank
PE N/A
Fwd PE 8.12
BZUN Price Earnings VS Forward Price EarningsBZUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BZUN indicates a somewhat cheap valuation: BZUN is cheaper than 76.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.65
BZUN Per share dataBZUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BZUN's earnings are expected to grow with 99.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y134.34%
EPS Next 3Y99.3%

0

5. Dividend

5.1 Amount

No dividends for BZUN!.
Industry RankSector Rank
Dividend Yield N/A

BAOZUN INC-SPN ADR

NASDAQ:BZUN (11/28/2025, 1:30:02 PM)

2.86

+0.09 (+3.25%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)11-25 2025-11-25/bmo
Earnings (Next)03-18 2026-03-18/amc
Inst Owners19.4%
Inst Owner Change3.4%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap165.47M
Revenue(TTM)9.42B
Net Income(TTM)-184.87M
Analysts84.62
Price Target4.27 (49.3%)
Short Float %3.02%
Short Ratio1.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-52.71%
Min EPS beat(2)-137.06%
Max EPS beat(2)31.65%
EPS beat(4)2
Avg EPS beat(4)-102.48%
Min EPS beat(4)-346.95%
Max EPS beat(4)42.43%
EPS beat(8)3
Avg EPS beat(8)-194.53%
EPS beat(12)4
Avg EPS beat(12)-232.34%
EPS beat(16)5
Avg EPS beat(16)-274.34%
Revenue beat(2)1
Avg Revenue beat(2)0.84%
Min Revenue beat(2)-0.42%
Max Revenue beat(2)2.11%
Revenue beat(4)3
Avg Revenue beat(4)3.74%
Min Revenue beat(4)-0.42%
Max Revenue beat(4)12.85%
Revenue beat(8)4
Avg Revenue beat(8)1.25%
Revenue beat(12)4
Avg Revenue beat(12)-0.94%
Revenue beat(16)5
Avg Revenue beat(16)-1.01%
PT rev (1m)2.87%
PT rev (3m)12.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-42.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.95%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.12
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B 0.31
P/tB 0.38
EV/EBITDA 9.65
EPS(TTM)-0.17
EYN/A
EPS(NY)0.35
Fwd EY12.32%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS23.59
BVpS9.24
TBVpS7.54
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.92%
ROE -4.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.15%
FCFM N/A
ROA(3y)-3.64%
ROA(5y)-1.73%
ROE(3y)-9.17%
ROE(5y)-5.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.23%
GM growth 5Y3.57%
F-ScoreN/A
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Debt/EBITDA 13.54
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.97
Quick Ratio 1.69
Altman-Z 1.37
F-ScoreN/A
WACC2.49%
ROIC/WACCN/A
Cap/Depr(3y)102.69%
Cap/Depr(5y)116.63%
Cap/Sales(3y)2.63%
Cap/Sales(5y)2.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.85%
EPS Next Y276.97%
EPS Next 2Y134.34%
EPS Next 3Y99.3%
EPS Next 5Y84.98%
Revenue 1Y (TTM)6.92%
Revenue growth 3Y0.09%
Revenue growth 5Y5.3%
Sales Q2Q%1.11%
Revenue Next Year5.49%
Revenue Next 2Y4.54%
Revenue Next 3Y4.34%
Revenue Next 5Y4.95%
EBIT growth 1Y24.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year338.94%
EBIT Next 3Y80.32%
EBIT Next 5Y58%
FCF growth 1Y-149.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-77.46%
OCF growth 3YN/A
OCF growth 5Y-19.64%

BAOZUN INC-SPN ADR / BZUN FAQ

What is the fundamental rating for BZUN stock?

ChartMill assigns a fundamental rating of 3 / 10 to BZUN.


Can you provide the valuation status for BAOZUN INC-SPN ADR?

ChartMill assigns a valuation rating of 5 / 10 to BAOZUN INC-SPN ADR (BZUN). This can be considered as Fairly Valued.


What is the profitability of BZUN stock?

BAOZUN INC-SPN ADR (BZUN) has a profitability rating of 2 / 10.


What is the expected EPS growth for BAOZUN INC-SPN ADR (BZUN) stock?

The Earnings per Share (EPS) of BAOZUN INC-SPN ADR (BZUN) is expected to grow by 276.97% in the next year.